TickerFactsScreenerDevelopers

Summit Therapeutics Inc. (SMMT) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2019: $157.0K2020: $421.0K2021: $306.0K2022: $624.0K2023: $128.0K2024: $139.0K2025: $657.0K$657.0K
2019Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$657.0K+372.7%
2024$139.0K+8.6%
2023$128.0K-79.5%
2022$624.0K+103.9%
2021$306.0K-27.3%
2020$421.0K+168.2%
2019$157.0K—